Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra P Loren

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Blood|July 16, 2011
S6K1 and mTOR regulate Rac1-driven platelet activation and aggregationJoseph E Aslan, Garth W Tormoen, Cassandra P Loren, et al.
Journal of Molecular Signaling|September 3, 2011
Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in plateletsJoseph E Aslan, Alex M Spencer, Cassandra P Loren, et al.
Thrombosis Research|December 21, 2014
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shearCassandra P Loren, Joseph E Aslan, Rachel A Rigg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shearJoseph E Aslan, Asako Itakura, Kristina M Haley, et al.
American Journal of Physiology. Cell Physiology|December 15, 2015
Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet functionRachel A Rigg, Joseph E Aslan, Laura D Healy, et al.
American Journal of Physiology. Cell Physiology|June 21, 2013
The PAK system links Rho GTPase signaling to thrombin-mediated platelet activationJoseph E Aslan, Sandra M Baker, Cassandra P Loren, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Blood|July 16, 2011
S6K1 and mTOR regulate Rac1-driven platelet activation and aggregationJoseph E Aslan, Garth W Tormoen, Cassandra P Loren, et al.
Journal of Molecular Signaling|September 3, 2011
Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in plateletsJoseph E Aslan, Alex M Spencer, Cassandra P Loren, et al.
Thrombosis Research|December 21, 2014
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shearCassandra P Loren, Joseph E Aslan, Rachel A Rigg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shearJoseph E Aslan, Asako Itakura, Kristina M Haley, et al.
American Journal of Physiology. Cell Physiology|December 15, 2015
Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet functionRachel A Rigg, Joseph E Aslan, Laura D Healy, et al.
American Journal of Physiology. Cell Physiology|June 21, 2013
The PAK system links Rho GTPase signaling to thrombin-mediated platelet activationJoseph E Aslan, Sandra M Baker, Cassandra P Loren, et al.
Pageof 1